Frequency Therapeutics, Inc. (Nasdaq: FREQ), relating to its proposed merger with Korro Bio, Inc. Under the terms of the agreement, FREQ shareholders are expected to own approximately 8% of the combined company
Frequency Therapeutics, Inc. (Nasdaq: FREQ), relating to its proposed merger with Korro Bio, Inc. Under the terms of the agreement, FREQ shareholders are expected to own approximately 8% of the combined company